CN1G.DE vs. NVO
Compare and contrast key facts about Amundi MSCI Nordic UCITS ETF EUR (C) (CN1G.DE) and Novo Nordisk A/S (NVO).
CN1G.DE is a passively managed fund by Amundi that tracks the performance of the MSCI Nordic Countries. It was launched on Mar 22, 2018.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CN1G.DE or NVO.
Key characteristics
| CN1G.DE | NVO | |
|---|---|---|
| YTD Return | 4.41% | 5.19% |
| 1Y Return | 14.58% | 6.93% |
| 3Y Return (Ann) | 2.29% | 25.01% |
| 5Y Return (Ann) | 10.56% | 32.22% |
| 10Y Return (Ann) | 8.77% | 19.81% |
| Sharpe Ratio | 1.07 | 0.23 |
| Sortino Ratio | 1.58 | 0.56 |
| Omega Ratio | 1.19 | 1.07 |
| Calmar Ratio | 1.38 | 0.25 |
| Martin Ratio | 3.82 | 0.75 |
| Ulcer Index | 3.78% | 9.32% |
| Daily Std Dev | 13.51% | 30.22% |
| Max Drawdown | -32.36% | -71.30% |
| Current Drawdown | -9.63% | -26.46% |
Correlation
The correlation between CN1G.DE and NVO is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
CN1G.DE vs. NVO - Performance Comparison
In the year-to-date period, CN1G.DE achieves a 4.41% return, which is significantly lower than NVO's 5.19% return. Over the past 10 years, CN1G.DE has underperformed NVO with an annualized return of 8.77%, while NVO has yielded a comparatively higher 19.81% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CN1G.DE vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amundi MSCI Nordic UCITS ETF EUR (C) (CN1G.DE) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CN1G.DE vs. NVO - Dividend Comparison
CN1G.DE has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 1.34%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CN1G.DE Amundi MSCI Nordic UCITS ETF EUR (C) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 1.34% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% | 1.72% |
Drawdowns
CN1G.DE vs. NVO - Drawdown Comparison
The maximum CN1G.DE drawdown since its inception was -32.36%, smaller than the maximum NVO drawdown of -71.30%. Use the drawdown chart below to compare losses from any high point for CN1G.DE and NVO. For additional features, visit the drawdowns tool.
Volatility
CN1G.DE vs. NVO - Volatility Comparison
The current volatility for Amundi MSCI Nordic UCITS ETF EUR (C) (CN1G.DE) is 3.62%, while Novo Nordisk A/S (NVO) has a volatility of 6.49%. This indicates that CN1G.DE experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.